Evidence map›Paper›PMID 25458354›Full record

ReviewAdvances in protein chemistry and structural biology2014

Biophysical studies of matrix metalloproteinase/triple-helix complexes.

Gregg B Fields

Abstract readReview
In one paragraph

Review in Advances in protein chemistry and structural biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. The roles of collagen in chronic kidney disease and vascular calcification.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  3. Review
  4. Integrin αExperimental physiology · 2018
    Article
  5. New strategies for targeting matrix metalloproteinases.Matrix biology : journal of the International Society for Matrix Biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gregg B FieldsTorrey Pines Institute for Molecular Studies, Port St. Lucie, Florida, USA. Electronic address: gfields@tpims.org.
Torrey Pines Institute For Molecular Studies · US

Funding

Mechanism &Inhibition of Collagenolytic ActivityR01CA098799 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FIELDS, GREGG B · 2003 to 2017
$4.5M
New probes for matrix metalloproteinase 13R01AR063795 · NIAMS · TORREY PINES INST FOR MOLECULAR STUDIES · PI FIELDS, GREGG B · 2013 to 2015
$1.5M
NCI NIH HHS CA98799NCI NIH HHS R01 CA098799NIAMS NIH HHS AR063795NIAMS NIH HHS R01 AR063795PHS HHS 268201000036C-0-0-1
6 · The paper itself

Abstract

Several members of the zinc-dependent matrix metalloproteinase (MMP) family catalyze collagen degradation. The structures of MMPs, in solution and solid state and in the presence and absence of triple-helical collagen models, have been assessed by NMR spectroscopy, small-angle X-ray scattering, and X-ray crystallography. Structures observed in solution exhibit flexibility between the MMP catalytic (CAT) and hemopexin-like (HPX) domains, while solid-state structures are relatively compact. Evaluation of the maximum occurrence (MO) of MMP-1 conformations in solution found that, for all the high MO conformations, the CAT and HPX domains are not in tight contact, and the residues of the HPX domain reported to be responsible for the binding to the collagen triple-helix are solvent exposed. A mechanism for collagenolysis has been developed based on analysis of MMP solution structures. Information obtained from solid-state structures has proven valuable for analyzing specific contacts between MMPs and the collagen triple-helix.

Indexed as

Catalytic DomainCollagenHumansHydrolysisMatrix Metalloproteinase 1Models, MolecularProtein Interaction Domains and MotifsProtein Structure, SecondarySolutionsCollagenMatrix Metalloproteinase 1SolutionsCollagenCollagenolysisMatrix metalloproteinaseMaximum occurrenceProteolysisTriple-helix

Identifiers

PMID25458354
PMCPMC4337812
OpenAlexW2329082197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.